Zobrazeno 1 - 10
of 48
pro vyhledávání: '"George M Viola"'
Autor:
Hiba Dagher, Anne-Marie Chaftari, Patricia Mulanovich, Ying Jiang, Ray Hachem, Alexandre E Malek, Jovan Borjan, George M Viola, Issam Raad
Publikováno v:
eLife, Vol 11 (2022)
Background: Procalcitonin (PCT) has been used to guide antibiotic therapy in bacterial infections. We aimed to determine the role of PCT in decreasing the duration of empiric antibiotic therapy among cancer patients admitted with COVID-19. Methods: T
Externí odkaz:
https://doaj.org/article/f0c93407e51a4839a5bd6cef9a3527b1
Autor:
Jose Banchs, Juhee Song, Saamir A Hassan, Cullen Grable, George M Viola, Owais Ulhaq, Corey T Jensen, Harsh Goel, Syed W Yusuf
Publikováno v:
Open Heart, Vol 8, Iss 2 (2021)
Background Infective endocarditis (IE) is more common in patients with cancer as compared with the general population. Due to an immunocompromised state, the need for invasive procedures, hypercoagulability and the presence of indwelling catheters, p
Externí odkaz:
https://doaj.org/article/e0175c21dcd74a5f9596d33afb63169f
Autor:
George M. Viola, Ariel D. Szvalb, Alexandre E. Malek, Anne‐Marie Chaftari, Ray Hachem, Issam I. Raad
Publikováno v:
CA: A Cancer Journal for Clinicians. 73:147-163
Over the past several years, multifaceted advances in the management of cancer have led to a significant improvement in survival rates. Throughout patients' oncological journeys, they will likely receive one or more implantable devices for the admini
Autor:
Hiba Dagher, Anne-Marie Chaftari, Patricia Mulanovich, Ying Jiang, Ray Hachem, Alexandre E Malek, Jovan Borjan, George M Viola, Issam Raad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abddabf5607775c6b28880b575ac546d
https://doi.org/10.7554/elife.81151.sa2
https://doi.org/10.7554/elife.81151.sa2
Autor:
Ariel D Szvalb, Claire A Marten, Katherine E Cain, Jolyn Taylor, Steven Y Huang, George M Viola
Publikováno v:
Open Forum Infectious Diseases. 9
Background Percutaneous nephrostomy tube infections (PCNIs) are complex, affect quality of life, necessitate implant exchanges, and increase health care costs. Here, we analyzed risk factors for recurrent PCNIs in patients treated with our standardiz
Autor:
George M. Viola, Cullen Grable, Syed Wamique Yusuf, Harsh Goel, Saamir Hassan, Jose Banchs, Corey T. Jensen, Owais Ulhaq, Juhee Song
Publikováno v:
Open Heart, Vol 8, Iss 2 (2021)
Open Heart
Open Heart
BackgroundInfective endocarditis (IE) is more common in patients with cancer as compared with the general population. Due to an immunocompromised state, the need for invasive procedures, hypercoagulability and the presence of indwelling catheters, pa
Publikováno v:
Infection Control & Hospital Epidemiology. 40:1036-1045
The proper functioning of central lines is imperative for the management of patients with cancer or on hemodialysis. However, these lifelines can become infected and can malfunction.Chelators such as citrate and EDTA have been widely studied alone or
Autor:
Tomoki Nishiguchi, Dimitrios P. Kontoyiannis, Steven M. Holland, Alexandre E. Malek, Lindsey B. Rosen, Pablo C. Okhuysen, George M. Viola, Andrew R. DiNardo
Publikováno v:
MycosesREFERENCES. 64(6)
The development of disseminated cryptococcosis has historically occurred in patients living with advanced human immunodeficiency virus or other immunosuppressive conditions affecting T-cell function. Recently, patients with anti-cytokine neutralising
Autor:
Kaveh Karimzad, Issam I Raad, Alexandre E. Malek, Jean-Bernard Durand, George M. Viola, Melissa Khalil
Publikováno v:
Open Forum Infectious Diseases
Background Oncological patients have several additional risk factors for developing a cardiac implantable electronic device (CIED)–related infection. Therefore, we evaluated the clinical impact of our comprehensive bundle approach that includes the
Autor:
Anne Marie Chaftari, Victor E. Mulanovich, Patrick Chaftari, Issam I Raad, Ying Jiang, Ray Y Hachem, Melissa Khalil, Alexandre E. Malek, Johny Fares, Frank V. Fossella, Dimitrios P. Kontoyiannis, George M. Viola
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 73(9)
BackgroundCheckpoint inhibitor (CPI) immunotherapy has revolutionized cancer treatment. However, immune-related adverse events and the risk of infections are not well studied. To assess the infectious risk of CPIs, we evaluated the incidence of infec